Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Semaglutide Reduces Asthma Attacks by Nearly 40%, Study Shows

1w ago September 8, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

Research presented at the European Respiratory Society Congress indicates that semaglutide, a diabetes and weight-loss injection, can reduce asthma attacks by nearly 40%. The study was led by Chloe Bloom from Imperial College London and presented by Dr. Bohee Lee. This finding could have implications for healthcare strategies in Iran, particularly in managing respiratory diseases.

🔍 Quick Context Guide
💡 Bottom Line: Semaglutide's potential to reduce asthma attacks could transform treatment approaches for respiratory diseases.

👥 Key Players

Chloe Bloom MENTIONED
Clinical Associate Professor in Respiratory Epidemiology
"Her research could influence asthma treatment strategies in Iran, where respiratory diseases are prevalent."
Dr. Bohee Lee MENTIONED
Presenter of the study
"As the presenter, he plays a crucial role in disseminating important findings that could impact healthcare policies."

📰 What Happened

A study presented at the European Respiratory Society Congress found that semaglutide, a drug typically used for diabetes and weight loss, can reduce asthma attacks by nearly 40%. This discovery could lead to new treatment options for asthma patients.

  • Semaglutide is primarily known for treating diabetes and aiding weight loss.
  • The study was conducted by researchers at Imperial College London.

💡 Why It Matters

🇮🇷 For Iran: This finding could enhance asthma management in Iran, where air quality issues contribute to respiratory diseases.
🌍 Regional: Improved asthma treatment could reduce healthcare burdens in the region, where respiratory diseases are common.
🌐 International: This research may prompt further studies globally, influencing asthma treatment protocols and pharmaceutical markets.

📚 Background

Asthma is a significant health issue worldwide, and existing treatments may not be effective for all patients. Semaglutide's new application could provide a breakthrough.

Asthma management Pharmaceutical research
📡 Source: NEUTRAL
📊 Confidence: 70%
The article presents research findings from a reputable medical congress, indicating a focus on scientific evidence.

The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain. The study was led by Chloe Bloom, clinical associate professor in respiratory epidemiology at the National Heart & Lung Institute, Imperial College London, UK, and presented by Dr. Bohee Lee.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →